2 February 2024
Who does this notice affect?
Clients in the import and shipping industries—including freight forwarders, importers and customs brokers—associated with importing goods that require BMSB treatment during the BMSB risk season (goods manufactured in or shipped from target risk countries, that have been shipped between 1 September and 30 April (inclusive)).
What has changed?
Fumigat Srl (AEI: IT4007SB) has been reinstated under the offshore BMSB treatment provider scheme and listed as ‘approved’ on the List of Treatment Providers.
The company is ‘approved’ to perform heat and sulfuryl fluoride treatments on Australian and New Zealand bound consignments.
The ‘approved’ date is published on the summary of recent changes in the ‘change date’ column on the offshore treatment provider website.
All treatment certification issued by the treatment provider will be considered unacceptable during the period the treatment provider was 'under review'. This also applies to goods in-transit.
Consignments or goods are classified as ‘in transit’ when they have left the country of origin but have not yet been cleared through the border in Australia. Please refer to Biosecurity Import Conditions system (BICON) for onshore outcomes.
Further information
For further information, please contact Compliance Partnerships at BMSBtreatments@aff.gov.au for treatment related questions or Hitchhiker and Ports Policy team at SPP@aff.gov.au for onshore outcome.